A Profile of the Efficacy of Sarilumab Plus Methotrexate in Rheumatoid Arthritis Patients: Results of a 52-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study. Kavanaugh, A., Decktor, D. L., Fan, C., van Adelsberg, J., Martincova, R., Genovese, M. C. WILEY-BLACKWELL. 2014: S1233–S1234

View details for Web of Science ID 000344384906059